Skip to main content

Fnac Darty: Merger control clearance from the European Commission of the takeover bid initiated by EP Group

THE DISSEMINATION, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IS NOT AUTHORIZED IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER COUNTRY WHERE SUCH COMMUNICATION WOULD VIOLATE APPLICABLE REGULATIONS Ivry-sur-Seine – France, October 20, 2026, 7:30 AM CET MERGER CONTROL CLEARANCE FROM THE EUROPEAN COMMISSION OFTHE TAKEOVER BID INITIATED BY EP GROUPMerger control clearance obtained by the European Commission Closing of the Offer expected beginning of November 2026Fnac Darty and EP FR HOLDCo, a company controlled by EP Group and set up for the purposes of the proposed public tender offer for the outstanding shares and OCEANEs of Fnac Darty (the “Offer”) announce that they have received the merger control clearance from the European Commission for the planned acquisition...

Continue reading

Coop Pank AS unaudited financial results for Q3 2026

Coop Pank AS unaudited financial results for Q3 2026 By the end of Q3 2026, Coop Pank had 240,600 customers, an increase of 5,000 (+2%) during the quarter and 19,000 (+9%) over the year. The bank had 113,900 active customers, an increase of 1,900 (+1.7%) during the quarter and 8,000 (+8%) over the year. In Q3 2026, the volume of deposits at Coop Pank increased by EUR 131 million (+6%) to reach EUR 2.32 billion. Deposits from private customers increased by EUR 20 million: demand deposits decreased by EUR 6 million and term deposits increased by EUR 26 million. Deposits from domestic business customers increased by EUR 51 million: demand deposits increased by EUR 106 million, while term deposits decreased by EUR 55 million. Deposits raised through platforms increased by EUR 60 million. Compared with Q3 2025, the volume of Coop Pank’s...

Continue reading

All 2026 targets achieved. Excellence in execution, focus on value creation

Revenue +7.2% like-for-like, adjusted EBITDA margin at 42% Levered Free Cash Flow positive for the first time since IPO FY2027 targets: accelerating value-creating growthKey figures(in millions of euros) FY2025 FY2026 YoY Change (%) YoY Change (%), like for like (LFL)Revenue 1,084.6 1,145.1 +5.6% +7.2%Adjusted EBITDA 437.8 480.5 +9.7%  As a % of revenue 40.4% 42.0% +1.6 pt  Capex (361.4) (372.9)(1) +3.2%  As a % of revenue (33.3)% (32.6%)(1) (0.6) pts  Levered Free Cash Flow(1) (27.0) 24.7 na  Octave Klaba, Chairman and CEO of OVHcloud, said: “Twelve months after my return, we have delivered on all of the targets we announced. Fourth-quarter revenue grew 10.5% on a like-for-like basis, and monthly revenue surpassed the €100 million milestone by the end of the fiscal year. FY 2026 was a year of discipline. We managed...

Continue reading

Cabka Reports Continued Revenue Growth and Strong Profitability in Q3 2026

Amsterdam, Netherlands – 20 October 2026 – Cabka N.V. (together with its subsidiaries “Cabka”, or the “Company”), a company specialized in transforming hard to recycle plastic waste into innovative Reusable Transport Packaging (RTP), listed at Euronext Amsterdam, today announces its trading update for the third quarter of 2026. Cabka continued its positive performance in the first nine months of 2026, recording revenue growth of 4% to €137.8 million, compared to €132.1 million in the same period last year. Third-quarter revenue amounted to €42.3 million, broadly stable year-on-year compared to €42.1 million in Q3 2025, consistent with the softer trading conditions anticipated at the half-year results. Profitability improved significantly, supported by a favorable product mix and continued cost discipline. Cabka recorded continued...

Continue reading

Basilea reports presentation of new data for fosmanogepix, isavuconazole and ceftobiprole at IDWeek 2026

 Highlights include oral presentations of pediatric data from the fosmanogepix Expanded Access Program and the activity of its active moiety, manogepix, against Candida auris isolatesAllschwil, Switzerland, October 20, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that new data on the phase 3 antifungal fosmanogepix, the antifungal isavuconazole (Cresemba®) and the antibiotic ceftobiprole (Zevtera®) will be presented at IDWeek 2026, which takes place from October 21 to 24 in Washington D.C., USA. Dr. Marc Engelhardt, Chief Medical Officer of Basilea, said: “The breadth of data being presented at IDWeek across Basilea’s anti-infectives portfolio by us, our partners, collaborators...

Continue reading

Grupo Aeroportuario del Pacifico Announces Results for the Third Quarter of 2026

GUADALAJARA, Mexico, Oct. 19, 2026 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) reports its consolidated results for the third quarter ended September 30, 2026 (3Q26). The results presented in this report include the effects of the business combination effective May 1, 2026. The figures are unaudited and have been prepared following International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”). Summary of Results 3Q26 vs. 3Q25The sum of aeronautical and non-aeronautical services revenues increased by Ps. 1,041.6 million, or 13.2%. Total revenues increased by Ps. 2,091.2 million, or 21.8%. Excluding the impact of the incorporation of Cross Border Xpress (“CBX”) operations, aeronautical and non-aeronautical...

Continue reading

Broadcom to Advance NTT DOCOMO’s Private Cloud with VMware Cloud Foundation

Company’s First 10-year VMware Software Agreement in Japan Strengthens Infrastructure Resilience and Lays the Foundation for Next-generation Services TOKYO, Oct. 19, 2026 (GLOBE NEWSWIRE) — Broadcom Inc. (NASDAQ: AVGO), a global technology leader that designs, develops, and supplies semiconductor and infrastructure software solutions, today announced that it has signed a 10-year agreement with NTT DOCOMO, INC. (DOCOMO) to continuously advance the private cloud that will underpin the company’s digital services over the next decade. The agreement will enable DOCOMO to continue delivering reliable digital services to its customers amid a rapidly changing business environment, marked by the expanding use of AI and increasingly sophisticated cyberattacks. Since 2019, VMware, now Broadcom, has worked closely with DOCOMO to build and operate...

Continue reading

Anteris Advances Global PARADIGM Trial Expansion with German Regulatory Clearance

MINNEAPOLIS and BRISBANE, Australia, Oct. 19, 2026 (GLOBE NEWSWIRE) — Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) announced today that it has received full regulatory clearance from the German Federal Institute for Drugs and Medical Devices (BfArM) for the DurAVR® Transcatheter Heart Valve (THV) global pivotal trial for patients with severe calcific aortic stenosis (the “PARADIGM Trial”). This clearance enables Anteris to initiate patient recruitment at leading German centers and represents an important step in expanding the PARADIGM Trial’s European footprint. Germany is Europe’s largest and most established transcatheter aortic valve replacement (TAVR) market, with an extensive network of experienced structural heart centers and investigators. Activating sites in this high-volume environment...

Continue reading

Cambria Gold Mines Announces Marketing Agreement with Maximus Strategic Consulting Inc.

VANCOUVER, British Columbia, Oct. 19, 2026 (GLOBE NEWSWIRE) — Cambria Gold Mines Inc. (TSXV: CAMB; OTCQX: CAMVF) (“Cambria” or the “Company”) announces that it has entered into an online marketing agreement in compliance with the policies and guidelines of the TSX Venture Exchange (“TSX-V”) with Maximus Strategic Consulting Inc. (“Maximus”). Pinnacle Digest and PinnacleDigest.com are business names of Maximus. Maximus has agreed to produce and distribute, through the email newsletter and YouTube channel of PinnacleDigest.com, a video highlighting the Company and its Premier Gold and Red Mountain projects. Additionally, all the Company’s news releases during the term of the online marketing agreement will be featured in Pinnacle Digest’s weekly email newsletter. The Company’s engagement of Maximus will run for a period of four months,...

Continue reading

Alkane Drilling Confirms and Extends Gold-Antimony Mineral System at Nagambie, Victoria

PERTH, Western Australia, Oct. 19, 2026 (GLOBE NEWSWIRE) — Alkane Resources Limited (ASX: ALK; TSX: ALK; OTCQX: ALKRY) (‘Alkane’) is pleased to announce the initial exploration results from an earn-in period in which Alkane has agreed to initially spend a total of $12.5M on exploration and evaluation activities to earn a 60% interest in the Nagambie property over three years, with the right to move to 80% with further expenditure.1 Program SummaryDrilling commenced at Nagambie in June 2026 targeting the north-south trending “C” vein orientation, which is interpreted to contain gold-antimony mineralisation. 3 holes (1,868m) have been drilled, logged and sampled at the time of this announcement. Initial assays received to date for the first of three new Alkane holes, confirm the highly mineralised nature and continuity of the epizonal...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.